Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Nuevocor operates as a preclinical-stage biotech company.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA
Asgard Therapeutics is a Biotechnology Company.
xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
C-mo is the solution providing a complete assessment of cough, adressing key use-cases across the patient management lifecycle.
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.
etherna develops mRNA and lipid nanoparticle solutions.
Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases.
Optina Diagnostics develops technology for the early detection of disease through the eye.
Boehringer Ingelheim Venture Fund has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Boehringer Ingelheim Venture Fund's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Nuevocor received $45.0M in a Series B round. Boehringer Ingelheim Venture Fund's total known invested capital is $983.2M.
Boehringer Ingelheim Venture Fund's average investment size is $19.3M across its portfolio of 60 companies.
Recent Boehringer Ingelheim Venture Fund portfolio additions include Glox Therapeutics, Actym Therapeutics, Inc., Centauri Therapeutics, TECregen, STRM.BIO. These companies were founded in 2020 or later.